Product Information
CARBAMAZEPINE ER 300 MG CAP is a generic product labeled by Apotex Corp., priced at $1.0771 per EA under NDC 60505280707. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Apotex Corp.NDC
60505280707
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA078986On Market Since
3/23/2012
Pharmacological Classes
Price Statistics
The NADAC for CARBAMAZEPINE ER 300 MG CAP has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0771 per EA |
|---|---|
| All-time high | $1.4793 (Dec 11, 2019) |
| All-time low | $0.6362 (Oct 17, 2018) |
| 52-week high | $1.1200 |
| 52-week low | $0.9520 |
| Median price | $1.1058 |
| Average price | $1.1108 |
| Largest weekly change | +73.2% (May 1, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBAMAZEPINE ER 300 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE ER 300 MG CAP, manufactured by Apotex Corp., is $1.0771 per EA (NDC 60505280707), effective Jun 24, 2026.
How has the price of CARBAMAZEPINE ER 300 MG CAP changed over time?
Over the history we have for it, the NADAC for CARBAMAZEPINE ER 300 MG CAP has declined 19.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE ER 300 MG CAP?
Since Nov 28, 2013, the NADAC for CARBAMAZEPINE ER 300 MG CAP has ranged from a low of $0.6362 (Oct 17, 2018) to a high of $1.4793 (Dec 11, 2019), with a median of $1.1058 per EA.
Are there cheaper alternatives to CARBAMAZEPINE ER 300 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CARBAMAZEPINE ER 300 MG CAP, but none are currently priced below it.
Who manufactures CARBAMAZEPINE ER 300 MG CAP?
CARBAMAZEPINE ER 300 MG CAP (NDC 60505280707) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification